0 XP   0   0   0

Unity Biotechnology Inc
Buy, Hold or Sell?

I guess you are interested in Unity Biotechnology Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Unity Biotechnology Inc

Let's start. I'm going to help you getting a better view of Unity Biotechnology Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Unity Biotechnology Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Unity Biotechnology Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Unity Biotechnology Inc. The closing price on 2022-09-30 was $0.3951 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Unity Biotechnology Inc Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

1.1. Profitability of Unity Biotechnology Inc.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Unity Biotechnology Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Unity Biotechnology Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 259,964.4% means that $2,599.64 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Unity Biotechnology Inc:

  • The MRQ is -5,566.5%. The company is making a huge loss. -2
  • The TTM is 259,964.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ-5,566.5%TTM259,964.4%-265,531.0%
TTM259,964.4%YOY-+259,964.4%
TTM259,964.4%5Y51,947.5%+208,016.9%
5Y51,947.5%10Y45,171.7%+6,775.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5,566.5%-242.4%-5,324.1%
TTM259,964.4%-275.9%+260,240.3%
YOY--342.1%+342.1%
5Y51,947.5%-475.7%+52,423.2%
10Y45,171.7%-561.7%+45,733.4%
1.1.2. Return on Assets

Shows how efficient Unity Biotechnology Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Unity Biotechnology Inc to the Biotechnology industry mean.
  • -10.8% Return on Assets means that Unity Biotechnology Inc generated $-0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Unity Biotechnology Inc:

  • The MRQ is -13.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -10.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.5%TTM-10.8%-2.6%
TTM-10.8%YOY-9.9%-1.0%
TTM-10.8%5Y-11.6%+0.8%
5Y-11.6%10Y-12.4%+0.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.5%-9.7%-3.8%
TTM-10.8%-8.7%-2.1%
YOY-9.9%-9.2%-0.7%
5Y-11.6%-11.5%-0.1%
10Y-12.4%-12.4%0.0%
1.1.3. Return on Equity

Shows how efficient Unity Biotechnology Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Unity Biotechnology Inc to the Biotechnology industry mean.
  • -32.9% Return on Equity means the company generated $-0.33 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Unity Biotechnology Inc:

  • The MRQ is -32.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -24.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-32.9%TTM-24.7%-8.2%
TTM-24.7%YOY-18.7%-5.9%
TTM-24.7%5Y-17.2%-7.5%
5Y-17.2%10Y-17.0%-0.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-32.9%-11.8%-21.1%
TTM-24.7%-11.1%-13.6%
YOY-18.7%-10.6%-8.1%
5Y-17.2%-13.5%-3.7%
10Y-17.0%-14.5%-2.5%

1.2. Operating Efficiency of Unity Biotechnology Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Unity Biotechnology Inc is operating .

  • Measures how much profit Unity Biotechnology Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Unity Biotechnology Inc to the Biotechnology industry mean.
  • An Operating Margin of -5,187.7% means the company generated $-51.88  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Unity Biotechnology Inc:

  • The MRQ is -5,187.7%. The company is operating very inefficient. -2
  • The TTM is -51,769,079.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-5,187.7%TTM-51,769,079.4%+51,763,891.6%
TTM-51,769,079.4%YOY--51,769,079.4%
TTM-51,769,079.4%5Y-10,353,862.1%-41,415,217.2%
5Y-10,353,862.1%10Y-9,003,358.4%-1,350,503.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5,187.7%-232.1%-4,955.6%
TTM-51,769,079.4%-269.6%-51,768,809.8%
YOY--309.3%+309.3%
5Y-10,353,862.1%-466.7%-10,353,395.4%
10Y-9,003,358.4%-572.5%-9,002,785.9%
1.2.2. Operating Ratio

Measures how efficient Unity Biotechnology Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 5,294.1% means that the operating costs are $52.94for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Unity Biotechnology Inc:

  • The MRQ is 52.941. The company is inefficient in keeping operating costs low. -1
  • The TTM is -2,429.524.
Trends
Current periodCompared to+/- 
MRQ52.941TTM-2,429.524+2,482.464
TTM-2,429.524YOY--2,429.524
TTM-2,429.5245Y-484.387-1,945.136
5Y-484.38710Y-421.206-63.181
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ52.9413.321+49.620
TTM-2,429.5243.542-2,433.066
YOY-3.491-3.491
5Y-484.3875.744-490.131
10Y-421.2067.007-428.213

1.3. Liquidity of Unity Biotechnology Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Unity Biotechnology Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 413.1% means the company has $4.13 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Unity Biotechnology Inc:

  • The MRQ is 4.131. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.164. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.131TTM5.164-1.034
TTM5.164YOY7.867-2.703
TTM5.1645Y8.850-3.685
5Y8.85010Y8.796+0.054
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1315.266-1.135
TTM5.1646.060-0.896
YOY7.8676.366+1.501
5Y8.8506.692+2.158
10Y8.7966.457+2.339
1.3.2. Quick Ratio

Measures if Unity Biotechnology Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Biotechnology industry mean)
  • A Quick Ratio of 667.3% means the company can pay off $6.67 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Unity Biotechnology Inc:

  • The MRQ is 6.673. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 7.670. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.673TTM7.670-0.997
TTM7.670YOY13.377-5.707
TTM7.6705Y14.492-6.821
5Y14.49210Y12.602+1.890
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.6734.055+2.618
TTM7.6704.865+2.805
YOY13.3775.192+8.185
5Y14.4925.275+9.217
10Y12.6024.997+7.605

1.4. Solvency of Unity Biotechnology Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Unity Biotechnology Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Asset Ratio of 0.59 means that Unity Biotechnology Inc assets are financed with 59.1% credit (debt) and the remaining percentage (100% - 59.1%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Unity Biotechnology Inc:

  • The MRQ is 0.591. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.551. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.591TTM0.551+0.040
TTM0.551YOY0.471+0.079
TTM0.5515Y0.376+0.175
5Y0.37610Y0.337+0.039
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5910.271+0.320
TTM0.5510.269+0.282
YOY0.4710.296+0.175
5Y0.3760.361+0.015
10Y0.3370.399-0.062
1.4.2. Debt to Equity Ratio

Measures if Unity Biotechnology Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Equity ratio of 144.4% means that company has $1.44 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Unity Biotechnology Inc:

  • The MRQ is 1.444. The company is able to pay all its debts with equity. +1
  • The TTM is 1.233. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.444TTM1.233+0.211
TTM1.233YOY0.898+0.336
TTM1.2335Y0.539+0.695
5Y0.53910Y0.475+0.063
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4440.310+1.134
TTM1.2330.311+0.922
YOY0.8980.310+0.588
5Y0.5390.382+0.157
10Y0.4750.438+0.037

2. Market Valuation of Unity Biotechnology Inc

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Unity Biotechnology Inc.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -0.59 means the investor is paying $-0.59 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Unity Biotechnology Inc:

  • The EOD is -0.417. Company is losing money. -2
  • The MRQ is -0.595. Company is losing money. -2
  • The TTM is -1.324. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-0.417MRQ-0.595+0.178
MRQ-0.595TTM-1.324+0.729
TTM-1.324YOY-2.887+1.563
TTM-1.3245Y-2.478+1.154
5Y-2.47810Y-2.155-0.323
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.417-2.115+1.698
MRQ-0.595-2.332+1.737
TTM-1.324-3.889+2.565
YOY-2.887-5.087+2.200
5Y-2.478-3.697+1.219
10Y-2.155-3.390+1.235
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Unity Biotechnology Inc.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Unity Biotechnology Inc:

  • The MRQ is 0.016. Very good. +2
  • The TTM is 0.039. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.016TTM0.039-0.023
TTM0.039YOY0.511-0.472
TTM0.0395Y0.251-0.212
5Y0.25110Y0.2510.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0160.003+0.013
TTM0.0390.019+0.020
YOY0.5110.042+0.469
5Y0.2510.020+0.231
10Y0.2510.017+0.234

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Unity Biotechnology Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.98 means the investor is paying $0.98 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Unity Biotechnology Inc:

  • The EOD is 0.685. Very good. +2
  • The MRQ is 0.978. Very good. +2
  • The TTM is 1.698. Good. +1
Trends
Current periodCompared to+/- 
EOD0.685MRQ0.978-0.293
MRQ0.978TTM1.698-0.720
TTM1.698YOY3.274-1.576
TTM1.6985Y2.340-0.643
5Y2.34010Y2.035+0.305
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.6851.843-1.158
MRQ0.9781.961-0.983
TTM1.6982.789-1.091
YOY3.2743.538-0.264
5Y2.3402.782-0.442
10Y2.0352.419-0.384

2.4. Latest News of Unity Biotechnology Inc

Does Unity Biotechnology Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Unity Biotechnology Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2022-09-19
14:00
UNITY Biotechnology Completes Enrollment in Phase 2 ENVISION Study of UBX1325 in Wet Age-related Macular DegenerationRead
2022-09-19
13:00
The Three Best Anti-Aging Stocks to Buy in SeptemberRead

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Unity Biotechnology Inc.

3.1. Institutions holding Unity Biotechnology Inc

Institutions are holding 34.597% of the shares of Unity Biotechnology Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-03-31FMR Inc3.07670.00022140917-965613-31.0833
2022-03-31PURA VIDA INVESTMENTS, LLC2.26790.0573157814015781400
2022-03-31Vanguard Group Inc1.61701125195-653614-36.7445
2022-03-31Renaissance Technologies Corp1.3030.0012906715-170985-15.8657
2022-03-31Millennium Management LLC1.08090.000575216320025536.2841
2022-03-31Marshall Wace Asset Management Ltd0.97420.0014677866-214111-24.0041
2022-06-30GSA Capital Partners LLP0.91960.0542639937-84265-11.6356
2022-03-31Baillie Gifford & Co Limited.0.84660.000558911100
2022-03-31Founders Fund V Management, LLC0.70670.035249175100
2022-06-30Geode Capital Management, LLC0.60020417640-2131-0.5077
2022-03-31Two Sigma Advisers, LLC0.48270.001335900-186800-35.7375
2022-03-31Bridgeway Capital Management, LLC0.33980.00512364502800013.4325
2022-03-31Caption Management, LLC0.32330.0032250002250000
2022-03-31Susquehanna International Group, LLP0.270187895-516147-73.312
2022-03-31Morgan Stanley - Brokerage Accounts0.20710144139-29173-16.8326
2022-03-31Two Sigma Investments LLC0.19420.0005135101-382707-73.9091
2022-03-31State Street Corporation0.155010784051004.964
2022-03-31Franklin Resources Inc0.133509290000
2022-03-31LPL Financial Corp0.10730.00017465057000322.9462
2022-03-31Northern Trust Corp0.0951066199-5-0.0076
Total 15.70080.160210925509  

3.2. Funds holding Unity Biotechnology Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-07-31Vanguard Total Stock Mkt Idx Inv1.0991076478900
2022-07-31Vanguard Extended Market Index Investor0.72330.000450331900
2022-06-30Fidelity Growth Compy Commingled Pl 30.65430.0005455300-135295-22.9083
2022-06-30Fidelity® Growth Company0.53090.0005369395-123863-25.1112
2022-05-31Edinburgh Worldwide Ord0.49020.023234111100
2022-06-30Baillie Gifford Global Discovery A Acc0.35830.012249316-4467-1.7602
2022-06-30Fidelity® Extended Market Index0.34970.000524333100
2022-06-30Bridgeway Ultra-Small Company Market0.27510.0568191450-45000-19.0315
2022-06-30Fidelity® Growth Company K60.16440.0007114415-28491-19.9369
2022-07-29iShares Micro-Cap ETF0.15840.007711021400
2022-06-30BlackRock Extended Mkt Composite0.10050.000369952699520
2022-06-30BlackRock Extended Equity Market K0.08960.0003623321140.1832
2022-06-30Franklin U.S. Small Cap Equity I0.08750.033160864-30236-33.1899
2022-06-30Fidelity® Series Total Market Index0.07520.00015233200
2022-06-30Fidelity® Total Market Index0.066204607600
2022-07-31Schwab Total Stock Market Index0.0660.00024595100
2022-06-30Fidelity® NASDAQ Composite Index®0.06580.00034580800
2022-06-30Northern Trust Extended Eq Market Idx0.04920.00053421200
2022-06-30NT Ext Equity Mkt Idx Fd - L0.04920.00053421200
2022-06-30NT Ext Equity Mkt Idx Fd - NL0.03940.00032739400
Total 5.49230.13793821773  

3.3. Insider Transactions

Insiders are holding 2.68% of the shares of Unity Biotechnology Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-08-01Anirvan GhoshSELL104460.67996916
2022-08-01Anirvan GhoshSELL104460.67996916
2022-08-01Anirvan GhoshSELL104460.67996916
2022-08-01Anirvan GhoshSELL104460.67996916
2022-08-01Anirvan GhoshSELL104460.67996916
2022-08-01Anirvan GhoshSELL104460.67996916
2022-08-01Anirvan GhoshSELL104460.67996916
2022-08-01Anirvan GhoshSELL104460.67996916
2022-08-01Anirvan GhoshSELL104460.67996916
2022-08-01Anirvan GhoshSELL104460.67996916
2022-08-01Anirvan GhoshSELL104460.67996916
2022-08-01Anirvan GhoshSELL104460.67996916
2022-08-01Anirvan GhoshSELL104460.67996916
2022-08-01Anirvan GhoshSELL104460.67996916
2022-08-01Anirvan GhoshSELL104460.67996916
2022-08-01Anirvan GhoshSELL104460.67996916
2022-08-01Anirvan GhoshSELL104460.67996916
2022-08-01Anirvan GhoshSELL104460.67996916
2022-08-01Anirvan GhoshSELL104460.67996916
2022-08-01Anirvan GhoshSELL104460.67996916

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Unity Biotechnology Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--0.5770.846-32%1.531-62%4.578-87%6.480-91%
Book Value Per Share Growth---0.174-0.156-10%-0.265+52%-1.391+699%0.026-764%
Current Ratio--4.1315.164-20%7.867-47%8.850-53%8.796-53%
Debt To Asset Ratio--0.5910.551+7%0.471+25%0.376+57%0.337+76%
Debt To Equity Ratio--1.4441.233+17%0.898+61%0.539+168%0.475+204%
Dividend Per Share----0%-0%-0%-0%
Eps---0.190-0.237+25%-0.378+100%-1.246+557%-0.874+361%
Eps Growth---37.348-35.269-6%-12.949-65%-17.922-52%-17.922-52%
Gains Per Share---0.174-0.156-10%-0.265+52%-1.391+699%0.026-764%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---55.6652599.644-102%--100%519.475-111%451.717-112%
Operating Margin---51.877-517690.794+997817%--100%-103538.621+199484%-90033.584+173452%
Operating Ratio--52.941-2429.524+4689%-+100%-484.387+1015%-421.206+896%
Pb Ratio0.685-43%0.9781.698-42%3.274-70%2.340-58%2.035-52%
Pe Ratio-0.417+30%-0.595-1.324+123%-2.887+386%-2.478+317%-2.155+262%
Peg Ratio--0.0160.039-59%0.511-97%0.251-94%0.251-94%
Price Per Share0.395-43%0.5641.536-63%4.835-88%5.925-90%5.152-89%
Quick Ratio--6.6737.670-13%13.377-50%14.492-54%12.602-47%
Return On Assets---0.135-0.108-20%-0.099-27%-0.116-13%-0.124-8%
Return On Equity---0.329-0.247-25%-0.187-43%-0.172-48%-0.170-48%
 EOD+2 -1MRQTTM+5 -13YOY+6 -125Y+7 -1110Y+5 -13

4.2. Fundamental Score

Let's check the fundamental score of Unity Biotechnology Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.417
Price to Book Ratio (EOD)Between0-10.685
Net Profit Margin (MRQ)Greater than0-55.665
Operating Margin (MRQ)Greater than0-51.877
Quick Ratio (MRQ)Greater than16.673
Current Ratio (MRQ)Greater than14.131
Debt to Asset Ratio (MRQ)Less than10.591
Debt to Equity Ratio (MRQ)Less than11.444
Return on Equity (MRQ)Greater than0.15-0.329
Return on Assets (MRQ)Greater than0.05-0.135
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Unity Biotechnology Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.282
Ma 20Greater thanMa 500.449
Ma 50Greater thanMa 1000.625
Ma 100Greater thanMa 2000.658
OpenGreater thanClose0.411
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets97,593
Total Liabilities57,662
Total Stockholder Equity39,931
 As reported
Total Liabilities 57,662
Total Stockholder Equity+ 39,931
Total Assets = 97,593

Assets

Total Assets97,593
Total Current Assets67,822
Long-term Assets67,822
Total Current Assets
Cash And Cash Equivalents 19,442
Short-term Investments 45,065
Other Current Assets 3,315
Total Current Assets  (as reported)67,822
Total Current Assets  (calculated)67,822
+/-0
Long-term Assets
Property Plant Equipment 28,813
Other Assets 958
Long-term Assets  (as reported)29,771
Long-term Assets  (calculated)29,771
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities16,419
Long-term Liabilities41,243
Total Stockholder Equity39,931
Total Current Liabilities
Short-term Debt 7,087
Short Long Term Debt 7,087
Accounts payable 1,437
Other Current Liabilities 7,895
Total Current Liabilities  (as reported)16,419
Total Current Liabilities  (calculated)23,506
+/- 7,087
Long-term Liabilities
Long term Debt Total 12,670
Capital Lease Obligations 28,573
Long-term Liabilities  (as reported)41,243
Long-term Liabilities  (calculated)41,243
+/-0
Total Stockholder Equity
Common Stock7
Retained Earnings -432,076
Accumulated Other Comprehensive Income -187
Capital Surplus 472,187
Total Stockholder Equity (as reported)39,931
Total Stockholder Equity (calculated)39,931
+/-0
Other
Capital Stock7
Cash and Short Term Investments 64,507
Common Stock Shares Outstanding 69,248
Common Stock Total Equity7
Liabilities and Stockholders Equity 97,593
Net Debt 28,888
Net Invested Capital 59,688
Net Tangible Assets 39,931
Net Working Capital 51,403
Short Long Term Debt Total 48,330



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
96,648
0
0
0
102,024
144,102
208,456
194,721
181,375
160,797
154,210
141,678
151,221
157,787
164,698
174,971
156,319
148,185
136,263
125,691
124,712
112,469
97,593
97,593112,469124,712125,691136,263148,185156,319174,971164,698157,787151,221141,678154,210160,797181,375194,721208,456144,102102,02400096,648
   > Total Current Assets 
93,409
0
0
0
88,880
136,439
187,621
179,816
172,965
151,840
141,427
125,873
129,487
115,233
123,537
135,690
100,866
102,041
87,608
84,726
90,504
81,483
67,822
67,82281,48390,50484,72687,608102,041100,866135,690123,537115,233129,487125,873141,427151,840172,965179,816187,621136,43988,88000093,409
       Cash And Cash Equivalents 
89,286
0
0
0
7,298
62,754
34,165
28,897
15,399
34,249
23,113
36,768
37,473
25,059
39,592
48,581
17,807
26,842
13,498
21,994
32,905
16,446
19,442
19,44216,44632,90521,99413,49826,84217,80748,58139,59225,05937,47336,76823,11334,24915,39928,89734,16562,7547,29800089,286
       Short-term Investments 
0
0
0
0
79,212
71,281
151,806
148,917
155,736
115,949
104,889
76,206
90,015
88,299
79,944
83,633
79,892
73,617
70,445
58,973
55,170
62,717
45,065
45,06562,71755,17058,97370,44573,61779,89283,63379,94488,29990,01576,206104,889115,949155,736148,917151,80671,28179,2120000
       Net Receivables 
0
0
0
0
1,382
0
0
0
0
0
10,650
10,650
0
0
0
0
0
0
0
0
0
0
0
0000000000010,65010,650000001,3820000
       Other Current Assets 
4,123
0
0
0
988
2,404
1,650
2,002
1,830
1,642
13,425
12,899
7,506
5,995
11,769
3,476
3,167
1,582
3,665
3,759
57,599
2,320
3,315
3,3152,32057,5993,7593,6651,5823,1673,47611,7695,9957,50612,89913,4251,6421,8302,0021,6502,4049880004,123
   > Long-term Assets 
0
0
0
0
13,144
7,663
20,835
14,905
8,410
8,957
12,783
15,805
21,734
42,554
41,161
39,281
55,453
46,144
48,655
40,965
34,208
30,986
29,771
29,77130,98634,20840,96548,65546,14455,45339,28141,16142,55421,73415,80512,7838,9578,41014,90520,8357,66313,1440000
       Property Plant Equipment 
2,248
0
0
0
6,958
6,591
6,595
6,345
6,238
5,880
5,658
5,359
16,636
40,510
39,117
37,833
12,627
34,908
33,667
32,464
31,228
30,014
28,813
28,81330,01431,22832,46433,66734,90812,62737,83339,11740,51016,6365,3595,6585,8806,2386,3456,5956,5916,9580002,248
       Long Term Investments 
0
0
0
0
5,118
0
12,073
6,386
0
0
4,040
7,353
3,025
0
0
0
17,871
9,790
13,542
7,500
1,993
0
0
001,9937,50013,5429,79017,8710003,0257,3534,040006,38612,07305,1180000
       Long-term Assets Other 
0
0
0
0
1,068
1,072
2,167
2,174
2,172
3,077
3,085
3,093
2,073
2,044
2,044
1,448
24,955
1,446
1,446
1,001
-52,190
972
958
958972-52,1901,0011,4461,44624,9551,4482,0442,0442,0733,0933,0853,0772,1722,1742,1671,0721,0680000
> Total Liabilities 
7,095
0
0
0
11,181
242,733
13,387
15,205
20,682
14,194
27,160
26,961
30,514
52,458
52,439
76,870
73,439
68,232
70,346
67,954
65,143
61,778
57,662
57,66261,77865,14367,95470,34668,23273,43976,87052,43952,45830,51426,96127,16014,19420,68215,20513,387242,73311,1810007,095
   > Total Current Liabilities 
3,691
0
0
0
7,897
10,663
9,405
11,690
16,582
11,111
15,232
14,318
17,216
14,569
15,669
16,925
14,463
10,269
13,395
12,977
16,617
17,905
16,419
16,41917,90516,61712,97713,39510,26914,46316,92515,66914,56917,21614,31815,23211,11116,58211,6909,40510,6637,8970003,691
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,520
33,264
32,036
945
3,055
4,837
7,087
7,0874,8373,05594532,03633,2644,5200000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
945
3,055
4,837
7,087
7,0874,8373,0559450000000000000000000
       Accounts payable 
964
0
0
0
2,378
10,663
8,680
10,081
13,628
4,071
5,381
4,578
5,185
4,015
3,952
16,925
2,558
1,975
1,898
1,773
1,985
3,323
1,437
1,4373,3231,9851,7731,8981,9752,55816,9253,9524,0155,1854,5785,3814,07113,62810,0818,68010,6632,378000964
       Other Current Liabilities 
2,727
0
0
0
5,519
5,626
725
1,609
2,954
446
2,270
1,156
3,217
910
1,816
12,670
7,385
8,294
11,497
10,259
11,361
9,529
7,895
7,8959,52911,36110,25911,4978,2947,38512,6701,8169103,2171,1562,2704462,9541,6097255,6265,5190002,727
   > Long-term Liabilities 
0
0
0
0
3,284
232,070
3,982
3,515
4,100
3,083
11,928
12,643
13,298
37,889
36,770
59,945
24,508
57,963
56,951
54,977
48,526
43,873
41,243
41,24343,87348,52654,97756,95157,96324,50859,94536,77037,88913,29812,64311,9283,0834,1003,5153,982232,0703,2840000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,313
24,508
24,699
24,892
24,142
0
0
12,670
12,6700024,14224,89224,69924,50824,313000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
37,889
36,770
35,632
34,468
0
0
29,867
31,417
24,502
21,486
21,48624,50231,41729,8670034,46835,63236,77037,8890000000000000
       Warrants
0
0
0
0
0
228,907
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000228,90700000
       Long-term Liabilities Other 
0
0
0
0
0
101
1,115
848
1,633
818
7
0
0
37,889
36,770
35,632
34,468
33,264
23
30,835
23
0
28,573
28,57302330,8352333,26434,46835,63236,77037,8890078181,6338481,11510100000
       Deferred Long Term Liability 
0
0
0
0
0
3,062
2,867
2,667
2,467
2,265
11,921
12,643
13,298
0
0
0
0
0
0
0
0
0
0
000000000013,29812,64311,9212,2652,4672,6672,8673,06200000
> Total Stockholder Equity
89,553
-41,536
0
0
90,843
-98,631
195,069
179,516
160,693
146,603
127,050
114,717
120,707
105,329
112,259
98,101
82,880
79,953
65,917
57,737
59,569
50,691
39,931
39,93150,69159,56957,73765,91779,95382,88098,101112,259105,329120,707114,717127,050146,603160,693179,516195,069-98,63190,84300-41,53689,553
   Common Stock
1
0
0
0
1
1
4
4
4
4
4
4
5
5
5
5
5
5
5
5
6
7
7
77655555555444444110001
   Retained Earnings Total Equity-432,07600-389,331-372,881-355,055-339,299-319,712-292,160-273,493-245,455-227,428-205,718-182,045-163,278-141,362-123,015-103,01300000
   Accumulated Other Comprehensive Income 
0
0
0
0
-104
-138
-77
-119
-95
19
113
95
90
373
232
66
5
15
5
6
-44
-176
-187
-187-176-446515566232373909511319-95-119-77-138-1040000
   Capital Surplus 
0
0
0
0
0
5,511
318,758
321,594
324,663
329,226
333,252
342,647
366,695
379,072
404,754
417,952
422,379
435,198
438,788
447,057
0
0
472,187
472,18700447,057438,788435,198422,379417,952404,754379,072366,695342,647333,252329,226324,663321,594318,7585,51100000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
-202
0
0
0
-306
-1,130
-678
-720
-696
-601
-488
-506
-538
-255
-340
417,742
82,870
434,988
438,788
447,057
459,631
469,799
472,187
472,187469,799459,631447,057438,788434,98882,870417,742-340-255-538-506-488-601-696-720-678-1,130-306000-202



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue5
Cost of Revenue--
Gross Profit-5
 
Operating Income (+$)
Gross Profit-
Operating Expense-61
Operating Income-56,665-61
 
Operating Expense (+$)
Research Development38
Selling General Administrative23
Selling And Marketing Expenses-
Operating Expense6161
 
Net Interest Income (+$)
Interest Income100
Interest Expense--3
Net Interest Income-3,077103
 
Pretax Income (+$)
Operating Income-56,665
Net Interest Income-3,077
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-61-113,269
EBIT - interestExpense = -56,662
-61
-64
Interest Expense-3
Earnings Before Interest and Taxes (ebit)-56,665-64
Earnings Before Interest and Taxes (ebitda)-64
 
After tax Income (+$)
Income Before Tax-61
Tax Provision--
Net Income From Continuing Ops-60,725-61
Net Income-61
Net Income Applicable To Common Shares-60,725
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net56,6043,077
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
VOLT.CC
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VOLT.CC.

VOLT.CC Daily Candlestick Chart
VOLLAR.CC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VOLLAR.CC.

VOLLAR.CC Daily Candlestick Chart
VIB.CC
6 hours ago

I found you a RSI Bullish Hidden Divergence on the daily chart of VIB.CC.

VIB.CC Daily Candlestick Chart
TRIO.CC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TRIO.CC.

TRIO.CC Daily Candlestick Chart
TKX.CC
6 hours ago

I found you a Golden Cross on the daily chart of TKX.CC.

TKX.CC Daily Candlestick Chart
TERC.CC
6 hours ago

I found you a Three Black Crows Candle Pattern on the daily chart of TERC.CC.

TERC.CC Daily Candlestick Chart
RENTBERRY.CC
6 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of RENTBERRY.CC.

RENTBERRY.CC Daily Candlestick Chart
STOX.CC
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of STOX.CC.

STOX.CC Daily Candlestick Chart
STO.CC
6 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of STO.CC.

STO.CC Daily Candlestick Chart
STM.CC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of STM.CC.

STM.CC Daily Candlestick Chart
SPORTS.CC
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SPORTS.CC.

SPORTS.CC Daily Candlestick Chart
SPIRIT.CC
6 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SPIRIT.CC.

SPIRIT.CC Daily Candlestick Chart
SHIELD.CC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHIELD.CC.

SHIELD.CC Daily Candlestick Chart
SHB.CC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHB.CC.

SHB.CC Daily Candlestick Chart
SFM.CC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SFM.CC.

SFM.CC Daily Candlestick Chart
QI.CC
6 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of QI.CC.

QI.CC Daily Candlestick Chart
PYRO.CC
6 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of PYRO.CC.

PYRO.CC Daily Candlestick Chart
PTF.CC
6 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PTF.CC.

PTF.CC Daily Candlestick Chart
PREMIA.CC
6 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PREMIA.CC.

PREMIA.CC Daily Candlestick Chart
POX.CC
6 hours ago

I found you a Death Cross on the daily chart of POX.CC.

POX.CC Daily Candlestick Chart
PLURA.CC
6 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of PLURA.CC.

PLURA.CC Daily Candlestick Chart
PLAY.CC
6 hours ago

I found you a MACD Bullish Hidden Divergence on the daily chart of PLAY.CC.

PLAY.CC Daily Candlestick Chart
PHR.CC
6 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of PHR.CC.

PHR.CC Daily Candlestick Chart
PAYT.CC
6 hours ago

I found you a MACD Bearish Hidden Divergence on the daily chart of PAYT.CC.

PAYT.CC Daily Candlestick Chart